Clinical Trials Browser

Phase EARLY_PHASE1 × Interventional × poly ICLC × Clear all

NCT00795457 2019-08-30

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

Phase EARLY_PHASE1 Completed

Astrocytoma, Glioma

NCT00986609 2018-07-23

MUC1 Vaccine for Triple-negative Breast Cancer

Phase EARLY_PHASE1 Completed

Breast Neoplasms, Inflammatory Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00874861 2015-12-08

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

Phase EARLY_PHASE1 Completed

Astrocytoma, Neoplasms, Oligodendroglioma